ITEM 1. Security and Issuer.
This Amendment No. 4 to Schedule 13D (this Amendment No. 4) is being filed by Exor N.V., a Dutch public limited liability
company (naamloze vennootschap) (Exor), to amend the Schedule 13D filed by Exor S.p.A., a società per azioni organized under the laws of the Republic of Italy, as predecessor in interest to Exor, with the Securities
and Exchange Commission (SEC) on October 22, 2014 (the Original 13D) as amended by Amendment No. 1 to Schedule 13D filed with the SEC on December 16, 2014 (Amendment No. 1), Amendment
No. 2 to Schedule 13D filed with the SEC on December 15, 2016 (Amendment No. 2) and Amendment No. 3 to Schedule 13D filed with the SEC on February 3, 2021 (Amendment No. 3, and together with the
Original Schedule 13D, Amendment No. 1, Amendment No. 2 and this Amendment No. 4 Schedule 13D), and relates to the common shares, par value 0.01 per share, of Stellantis N.V., a Dutch public limited liability company
(naamloze vennootschap) (the Issuer), the principal executive office of which is located at Singaporestraat 92, 1175 RA, Lijnden, The Netherlands. Each capitalized term used and not defined herein shall have the meaning assigned
to such term in the Original 13D, as amended. Except as otherwise provided herein, each Item of the Original 13D, as amended, remains unchanged.
This Amendment No. 4 is being filed to amend Item 2, Item 5 and Item 6 as follows.
ITEM 2. Identity and Background.
Item 2 is hereby amended and partially restated by replacing the first paragraph with the following:
(a)-(c) This Schedule 13D is filed by Exor N.V. (Exor or the Reporting Person), a Dutch public limited liability
company (naamloze vennootschap) and successor to Exor S.p.A. by virtue of a cross-border merger of Exor S.p.A. with and into Exor. Exor is an investment company, which focuses its business on long-term investments in global companies in
diversified sectors, mainly in Europe and the United States. The address of Exors principal business and principal office is Gustav Mahlerplein 25, 1082 MS, Amsterdam, The Netherlands. The name, business address, present principal occupation
or employment (and the name, principal business and address of any corporation or other organization in which such employment is conducted) and citizenship of each executive officer and director of Exor, each person controlling Exor and each
executive officer and director of any corporation or other person in control of Exor are set forth in Schedule A attached hereto.
ITEM 5.
Interest in Securities of the Issuer.
Item 5 is hereby amended and partially restated by replacing paragraphs (a) through (c)
with the following:
(a) Rows (11) and (13) of the cover pages to this Amendment No. 4 are incorporated by reference herein.
(b) Rows (7) through (10) of the cover pages to this Amendment No. 4 are hereby incorporated by reference herein.
Furthermore, the following persons listed in Item 2(a)(c) above beneficially own common shares of the Issuer:
3